The data suggest that CDK8 is largely dispensable for the initiation of BCR-ABL1p185+ or v-ABLp160+ B-ALL, but instead may play an important part in disease maintenance by controlling cell survival. Here, CDK8 is linked to acute lymphoblastic leukemia.